Published:  07, Nov 2026

Cannabis Market

Cannabis Market Size, Share and Analysis By Product Type (Flower, Concentrates, Edibles, Others), By Compound Type (THC-Dominant, CBD-Dominant, Balanced THC and CBD), By Application (Recreational, Medical), By Source (Marijuana, Hemp), By Distribution Channel (Dispensaries and Retail Stores, Online, Others) and Regional Forecast Till 2034.

Download Free Sample
banner icon
Market Size (2025):

USD 40,500.00 Million

banner icon
CAGR (2026–2034):

16.30%

banner icon
Report Pages:

170-180

banner icon
Market Tables:

55-65

Overview

The Cannabis Market was valued at USD 40,500.00 million in 2025 and is projected to reach USD 157,642.19 million by 2034, growing at a CAGR of 16.30% during the forecast period (2026–2034). The market is driven by wider legalization for medical and adult use, growing acceptance among consumers, new product formats such as edibles and concentrates, and rising use of cannabinoids in treatment of pain and other conditions.

 

The market is shifting toward medical-first supply, premium products and cross-border trade. Producers in Canada, Portugal, Czechia and other countries are exporting medical flower to Germany and other European markets, while companies add edibles, beverages, vapes and concentrates to meet consumer demand. Retailers and producers are consolidating to cut costs, and brands are investing in quality, genetics and consistent potency.

 

Government actions are central to the market. In the United States, federal authorities moved medical marijuana covered by state licenses and FDA-approved products from Schedule I to Schedule III in 2026, which eases some tax and research limits, while many states license medical and adult-use sale. Canada operates a national legal framework with provincial retail, Germany has expanded access to medical cannabis, and other European and Latin American countries are building regulated medical programs. By region, North America held the largest market share in 2025, supported by legal adult-use and medical sales across most United States states and all of Canada. Europe is projected to grow at the fastest CAGR during the forecast period, driven by expanding medical access in Germany and neighbouring countries, new import supply and moves toward regulated adult-use pilots.

Market Size & Share

CAGR (2026–2034):

Market Snapshot

Study Period: 2021-2034
Market Size in 2025: USD 40,500.00 Million
Market Size in 2026: USD 47,101.50 Million
Market Size by 2034: USD 157,642.19 Million
Unit Value: USD Million
Projected CAGR: 16.30% (2026-2034)
Largest Region: North America
Fastest-Growing Region: Europe
Fastest-Growing Product Type: Concentrates

Market Dynamics

KEY MARKET TREND:

Shift Toward Medical-First Supply, Cross-Border Trade and Premium Product Formats Emerging as a Transformational Trend

  • Licensed producers are building EU-GMP certified facilities and exporting medical flower to Europe, which links supply in Canada, Portugal and Czechia to demand in Germany and beyond.
  • Consumers are shifitng from dried flower toward edibles, beverages, vapes and concentrates with measured doses and discreet use, allowing companies to serve a wider range of consumption preferences.
  • Producers and retailers are consolidating, and companies are focusing on branded, premium and consistent-quality products to differentiate their offerings and strengthen their position in competitive legal markets.
  • The Federal Institute for Drugs and Medical Devices (BfArM) data reported showed that Germany imported about 201 tonnes of medical cannabis flower in 2025, up from about 73 tonnes in 2024, which shows how fast medical supply chains are growing.

 

KEY MARKET DRIVER

Legalization, Medical Access and Changing Consumer Attitudes Driving Market Growth

  • More countries and states license medical and adult-use sale, which moves consumers from illicit to legal supply and adds new retail outlets while expanding access through regulated distribution channels.
  • Patients and doctors use cannabinoids for chronic pain, nausea, sleep and neurological conditions, which supports pharmacy and prescription channels.
  • Consumers increasingly see cannabis as an alternative to alcohol and tobacco, and new formats make use easier to control while providing options for different consumer preferences and lifestyles.
  • The United Nations Office on Drugs and Crime reported that an estimated 256 million people used cannabis in 2024, the most widely used drug worldwide, which shows the size of the consumer base for legal supply.

 

KEY MARKET OPPORTUNITY

Regulated Adult-Use Pilots, Pharmaceutical Cannabinoids and Beverage Formats Creating New Growth Opportunities

  • Countries that now allow only medical sale, including several in Europe, may open regulated adult-use pilots, which would add large new consumer groups.
  • Pharmaceutical-grade cannabinoid medicines and clinical trials can open reimbursed prescription channels, supporting medical adoption and expanding opportunities for research-led product development.
  • Low-dose beverages, edibles and wellness products can reach consumers who do not smoke or vape, allowing manufacturers to target new customer segments with alternative consumption formats.
  • legal cannabis sales in Canada rose 6.1% in the year to March 2025 while prices fell 1.1% and alcohol purchases fell 1.6%, which shows continued volume growth and substitution in a mature market.
Cannabis Market Size, 2025-2034 (USD Million)

Segmentation Analysis

Analysis by Product Type

Flower held the largest market share in 2025 because dried cannabis flower and pre-rolls remain the most familiar, most widely sold and lowest-priced way to buy cannabis in both medical and adult-use markets. Dispensaries and pharmacies carry large ranges of strains with stated potency, and medical systems in Germany, Canada and Australia mostly dispense flower. Established cultivation, wide supplier choice and strong consumer habit keep flower ahead of concentrates, edibles and other products in total market value, even as newer formats take a growing share of spending.

 

Concentrates are projected to grow at the fastest CAGR during the forecast period as consumers and patients choose vape cartridges, oils, resins and extracts that give a stronger, more precise and more discreet dose. Extraction technology is improving, and brands are selling live resin, distillate and rosin at premium prices. Medical programs also favor oils and extracts for dose control. Growth starts from a smaller base than flower, which supports a higher rate of increase as legal markets mature and consumers trade up to higher-potency products.

 

Product Type categories include

                    ·           Flower (Dominating Segment)

                    ·           Concentrates (Highest CAGR Segment)

                    ·           Edibles

                    ·           Others

 

Analysis by Compound Type

THC-Dominant products held the largest market share in 2025 because most recreational consumers and many medical patients seek the psychoactive effects and symptom relief that come from THC. Flower, pre-rolls, vapes and edibles with high THC content make up most legal sales, and potency is a main factor in purchase choice and pricing. Retail menus in legal markets are built around THC strength. Strong consumer preference, the size of the adult-use market and the large share of medical products with THC keep THC-dominant products ahead of CBD-dominant and balanced products in total market value.

 

CBD-Dominant products are projected to grow at the fastest CAGR during the forecast period as interest rises in non-intoxicating products for sleep, anxiety, pain and general wellness. Pharmacies, health stores and online sellers offer oils, capsules, gummies and topicals, and clinical interest supports pharmaceutical use. Wider legal sale of hemp-derived products in several regions adds access. Growth starts from a smaller base than THC-dominant products in licensed cannabis markets, which supports a higher rate of increase as awareness and regulatory clarity improve.

 

Compound Type categories include

                    ·           THC-Dominant (Dominating Segment)

                    ·           CBD-Dominant (Highest CAGR Segment)

                    ·           Balanced THC and CBD

 

Analysis by Application

Recreational use held the largest market share in 2025 because adult-use sale is legal across most of Canada and in many United States states, and these are the largest legal markets by retail value. Consumers use dispensaries for flower, edibles, vapes and beverages, and prices, brands and product variety are developing quickly. Tax revenue and public support encourage governments to keep adult-use systems in place. The large number of adult consumers and high spending keep recreational use ahead of medical use in total market value.

 

Medical use is projected to grow at the fastest CAGR during the forecast period as Germany, other European countries, Australia, Latin America and Asia expand patient access and as the United States moves state-licensed medical marijuana to Schedule III. Doctors prescribe cannabis for chronic pain, spasticity, nausea and other conditions, and import supply is growing quickly. Reimbursement and clinical research support adoption. Growth starts from a smaller base than recreational use, which supports a higher rate of increase as medical programs spread to more countries.

 

Application categories include

                    ·           Recreational (Dominating Segment)

                    ·           Medical (Highest CAGR Segment)

 

Analysis by Source

Marijuana held the largest market share in 2025 because most licensed sales, in both adult-use and medical systems, involve high-THC plants grown and sold through dedicated cannabis retail channels. Licensed producers in North America, Europe and Australia cultivate marijuana in indoor, greenhouse and outdoor sites, and consumers buy flower, pre-rolls, vapes, edibles and extracts made from it. Strong brand building, broad legality in key markets and higher prices per unit keep marijuana ahead of hemp as the leading source in total market value.

 

Hemp is projected to grow at the fastest CAGR during the forecast period as hemp-derived CBD, minor cannabinoids and extracts are used in wellness products, beverages, pharmaceuticals and personal care items. Hemp can be grown at large scale on farms and is allowed in more countries than marijuana. Farming laws in several regions support production, and extraction companies seek stable supply. Growth starts from a smaller base than marijuana in licensed cannabis markets, which supports a higher rate of increase as regulations become clearer.

 

Source categories include

                    ·           Marijuana (Dominating Segment)

                    ·           Hemp (Highest CAGR Segment)

 

Analysis by Distribution Channel

Dispensaries and Retail Stores held the largest market share in 2025 because licensed adult-use sale in North America takes place mainly in physical stores, where staff advise customers and age checks are required. Stores carry broad ranges and offer loyalty programs, promotions and in-store experience. Rules in many jurisdictions limit or prohibit online sale and delivery. Established licensing, consumer habit and the need for direct oversight keep dispensaries and retail stores ahead of online and other channels in total market value.

 

Online is projected to grow at the fastest CAGR during the forecast period as more jurisdictions allow delivery, click-and-collect and telehealth with home delivery for medical patients. Germany, Australia and parts of the United States and Canada have seen strong growth in online prescriptions and digital ordering. Digital menus, subscriptions and data tools improve customer service. Growth starts from a smaller base than store sales, which supports a higher rate of increase as rules relax and consumers expect home delivery.

 

Distribution Channel categories include

                    ·           Dispensaries and Retail Stores (Dominating Segment)

                    ·           Online (Highest CAGR Segment)

                    ·           Others

By Region

Cannabis Market Regional Analysis

Cannabis Market Share 2025, (CAGR)
world map
location map

North America

52%

location map

South America

XX%

location map

Europe

22%

location map

Middle East Africa

XX%

location map

Asia Pacific

XX%

Regional Analysis

North America held the largest market share in 2025, driven primarily by the United States, where state-level legalization of medical and adult-use cannabis has supported a well-established commercial industry. Canada also contributes significantly through its federally regulated adult-use cannabis framework, established medical cannabis sector and expanding export activities. Mexico represents an emerging market, with evolving cannabis regulations and potential opportunities for future medical cannabis development. Companies such as Curaleaf, Trulieve, Green Thumb Industries, Canopy Growth and Tilray strengthen the regional industry through cultivation, processing and retail operations. However, high taxes, limited banking access, federal restrictions on interstate adult-use cannabis trade and competition from illicit supply may restrain growth, encouraging companies to focus on consolidation, brand development and operational efficiency.

 

Europe is projected to grow at the fastest CAGR during the forecast period, driven by expanding medical cannabis access and evolving regulatory frameworks across major countries. Germany leads regional demand, supported by broader medical cannabis access, increasing imports and a growing network of pharmacies and specialized suppliers. The United Kingdom has an established medical cannabis framework, with demand supported by specialist clinics and prescription-based access. France is gradually advancing its medical cannabis framework through regulatory developments and patient access initiatives, while Italy maintains a medical cannabis sector supported by prescription-based treatments and domestic cultivation initiatives. These countries contribute to regional demand through growing acceptance of cannabis-based treatments and evolving supply channels. Companies such as Sanity Group, Bedrocan, Aurora and Tilray strengthen regional supply through cultivation, processing and distribution activities. However, strict regulations, reimbursement limitations, concerns about prescription misuse and slow policy changes may restrain growth, encouraging suppliers to focus on EU-GMP quality standards and local production.

 

Countries and Regions Covered

North America (Dominating Region)

o  United States (Largest Country Market)

o  Canada

o  Mexico

Europe (Fastest Growing Region)

o  Germany (Largest Country Market)

o  United Kingdom

o  France

o  Italy

o  Rest of Europe

Asia Pacific

o  China

o  South Korea

o  Japan

o  India

o  Rest of Asia Pacific

Latin America

o  Brazil

o  Chile

o  Rest of Latin America

Middle East and Africa

o  Saudi Arabia

o  United Arab Emirates

o  Rest of Middle East and Africa

Market Share

The Cannabis Market is fragmented, with multi-state operators in the United States, licensed producers in Canada and Europe, and many small regional brands and retailers competing. Curaleaf, Trulieve, Green Thumb Industries, Verano and Cresco Labs lead in the United States, while Canopy Growth, Tilray, SNDL, Organigram and Cronos are the main Canadian producers with export operations. Jazz Pharmaceuticals leads in prescription cannabinoid medicines, and DEMECAN and Bedrocan serve European medical markets. Competition is shaped by licenses, brand strength, product quality, retail reach, cost of production and compliance, and consolidation is increasing. Deals between producers and retailers are common as firms seek scale.

 

Key Players

                    ·           Curaleaf Holdings, Inc. (United States)

                    ·           Trulieve Cannabis Corp. (United States)

                    ·           Green Thumb Industries Inc. (United States)

                    ·           Verano Holdings Corp. (United States)

                    ·           Cresco Labs Inc. (United States)

                    ·           Canopy Growth Corporation (Canada)

                    ·           Tilray Brands, Inc. (Canada)

                    ·           TerrAscend Corp. (Canada)

                    ·           SNDL Inc. (Canada)

                    ·           Organigram Global Inc. (Canada)

                    ·           Cronos Group Inc. (Canada)

                    ·           Jazz Pharmaceuticals plc (Ireland)

                    ·           Charlotte's Web Holdings, Inc. (United States)

                    ·           Glass House Brands Inc. (United States)

                    ·           DEMECAN GmbH (Germany)

 

Recent Market Developments

  • April 2026: Aurora Cannabis announced new medical cannabis product launches in Germany, Poland, Australia and Canada, including dried flower, pre-rolls and pastilles, with rollouts running through June 2026.
  • June 2026: Tilray Medical Germany launched ARX, its first premium medical cannabis brand cultivated in Germany at its Neumuenster facility under EU-GMP standards.

Frequently Asked Questions

What is the Cannabis Market?

The market covers licensed cannabis products from marijuana and hemp sold for recreational and medical use in jurisdictions where sale is legal.

What is driving the Cannabis Market growth?
What is the size of the Cannabis Market?
Which region dominates the Cannabis Market?
Which product type captures the largest market share?
Which application is growing the fastest?
Which distribution channel is growing the fastest?

Key Questions Answered

Request a Sample
1

What is the Cannabis Market?

2

What is driving the Cannabis Market growth?

3

What is the size of the Cannabis Market?

4

Which region dominates the Cannabis Market?

5

Which product type captures the largest market share?

6

Which product type is growing the fastest

7

Which application captures the largest market share?

Why Choose IG Transformation

Speak to Analyst
ico

Strong Industry Focus

ico

Extensive Product Offerings

ico

Customer Research Services

ico

Robust Research Methodology

ico

Comprehensive Reports

ico

Latest Technological Developments

ico

Value Chain Analysis

ico

Potential Market Opportunities

ico

Growth Dynamics

ico

Quality Assurance

ico

Post-sales Support

ico

Regular Report Updates

SINGLE USER ACCESS

$3950

  • PDF Report & Data Sheet
  • Delivered in 24-72 hrs. of purchase
  • 3-Months Analyst Support
  • One designated employee can access the report
bag ico
Buy Now

TEAM USER ACCESS

$4950

  • PDF Report & Data Sheet
  • Delivered in 24-72 hrs. of purchase
  • 3-Months Analyst Support
  • Up to 7 employees or consultants can access
bag ico
Buy Now

ENTERPRISE USER ACCESS

$5950

  • PDF Report & Data Sheet
  • Delivered in 24-72 hrs of purchase
  • 6-Months Analyst Support
  • Any employee, subsidiary, or consultant can access
bag ico
Buy Now

EXCEL SHEET ONLY

$2950

  • Full Excel Data Sheet
  • Delivered in 24-72 hrs of purchase
  • Raw data tables for independent analysis
  • Single-user access
bag ico
Buy Now

Email Subscription Management

By indicating your preferences, you give permission to send you reports, newsletters, invitations to seminars and other relevant marketing materials by email within your preferences.

Enquire Now

Empowering your business decisions through expert market research and seamless IT solutions.